182 related articles for article (PubMed ID: 36729917)
1. Vascular endothelial growth factor A is a potential prognostic biomarker and correlates with immune cell infiltration in hepatocellular carcinoma.
Qi Y; Song Y; Cai M; Li J; Yu Z; Li Y; Huang J; Jiang Y; Peng C; Jiang B; Liu S
J Cell Mol Med; 2023 Feb; 27(4):538-552. PubMed ID: 36729917
[TBL] [Abstract][Full Text] [Related]
2. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
[TBL] [Abstract][Full Text] [Related]
3. LOXL2 serves as a prognostic biomarker for hepatocellular carcinoma by mediating immune infiltration and vasculogenic mimicry.
Zhao N; Chen C; Guo Y; Liu T; Che N; Zhang D; Liang X; Zhang Y; Zhao X
Dig Liver Dis; 2023 May; 55(5):661-672. PubMed ID: 36192339
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinoma.
Pan L; Xiao H; Liao R; Chen Q; Peng C; Zhang Y; Mu T; Wu Z
Biomed Pharmacother; 2018 Oct; 106():68-76. PubMed ID: 29957468
[TBL] [Abstract][Full Text] [Related]
5. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
Dai K; Liu C; Guan G; Cai J; Wu L
BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B Virus Small Envelope Protein Promotes Hepatocellular Carcinoma Angiogenesis via Endoplasmic Reticulum Stress Signaling To Upregulate the Expression of Vascular Endothelial Growth Factor A.
Wu SX; Ye SS; Hong YX; Chen Y; Wang B; Lin XJ; Lin X
J Virol; 2022 Feb; 96(4):e0197521. PubMed ID: 34910612
[TBL] [Abstract][Full Text] [Related]
7. miR-361-5p inhibits hepatocellular carcinoma cell proliferation and invasion by targeting VEGFA.
Cui W; Li Y; Xu K; Chen G; Lu X; Duan Q; Kang Z
Biochem Biophys Res Commun; 2016 Oct; 479(4):901-906. PubMed ID: 27641667
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of myelin expression factor 2 in hepatocellular carcinoma.
Zhang P; Zhao JH; Chen L; Bian ZL; Ju LL; Wang HX; Cai WH
BMC Gastroenterol; 2023 Jan; 23(1):20. PubMed ID: 36658471
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA‑302a inhibits cell proliferation and invasion, and induces cell apoptosis in hepatocellular carcinoma by directly targeting VEGFA.
Qin C; Zha W; Fan R; Ding H; Xu Y; Wang C
Mol Med Rep; 2017 Nov; 16(5):6360-6367. PubMed ID: 28849033
[TBL] [Abstract][Full Text] [Related]
10. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
Huang S; Sun L; Hou P; Liu K; Wu J
Front Immunol; 2022; 13():944898. PubMed ID: 36148220
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma.
Lin J; Cao S; Wang Y; Hu Y; Liu H; Li J; Chen J; Li P; Liu J; Wang Q; Zheng L
J Exp Clin Cancer Res; 2018 Jun; 37(1):113. PubMed ID: 29866133
[TBL] [Abstract][Full Text] [Related]
12. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
[TBL] [Abstract][Full Text] [Related]
13. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.
Tian F; Cai D
Gene; 2022 Jan; 807():145964. PubMed ID: 34530087
[TBL] [Abstract][Full Text] [Related]
14. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
[TBL] [Abstract][Full Text] [Related]
15.
Yang YL; Tsai MC; Chang YH; Wang CC; Chu PY; Lin HY; Huang YH
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34206143
[TBL] [Abstract][Full Text] [Related]
16. Circ_0001178 regulates miR-382/VEGFA axis to facilitate hepatocellular carcinoma progression.
Gao S; Hu W; Huang X; Huang X; Chen W; Hao L; Chen Z; Wang J; Wei H
Cell Signal; 2020 Aug; 72():109621. PubMed ID: 32240747
[TBL] [Abstract][Full Text] [Related]
17. miR-34a-5p plays an inhibitory role in hepatocellular carcinoma by regulating target gene VEGFA.
Niu X; Wei N; Peng L; Li X; Zhang X; Wang C
Malays J Pathol; 2022 Apr; 44(1):39-52. PubMed ID: 35484885
[TBL] [Abstract][Full Text] [Related]
18. LncRNA OIP5-AS1 promotes cell proliferation and migration and induces angiogenesis via regulating miR-3163/VEGFA in hepatocellular carcinoma.
Shi C; Yang Q; Pan S; Lin X; Xu G; Luo Y; Zheng B; Xie X; Yu M
Cancer Biol Ther; 2020 Jul; 21(7):604-614. PubMed ID: 32329664
[TBL] [Abstract][Full Text] [Related]
19. PSG9 promotes angiogenesis by stimulating VEGFA production and is associated with poor prognosis in hepatocellular carcinoma.
Rong W; Yang L; Yin L; Gao Y; Xiao T; Cheng S
Sci China Life Sci; 2017 May; 60(5):528-535. PubMed ID: 28078509
[TBL] [Abstract][Full Text] [Related]
20. Cell division cycle associated 8: A novel diagnostic and prognostic biomarker for hepatocellular carcinoma.
Cui XH; Peng QJ; Li RZ; Lyu XJ; Zhu CF; Qin XH
J Cell Mol Med; 2021 Dec; 25(24):11097-11112. PubMed ID: 34741389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
